GLCGX
Price
$28.29
Change
+$0.26 (+0.93%)
Updated
May 8 closing price
Net Assets
1.36B
RGACX
Price
$70.16
Change
+$0.52 (+0.75%)
Updated
May 8 closing price
Net Assets
283.8B
Ad is loading...

GLCGX vs RGACX

Header iconGLCGX vs RGACX Comparison
Open Charts GLCGX vs RGACXBanner chart's image
Goldman Sachs Large Cap Gr Insghts A
Price$28.29
Change+$0.26 (+0.93%)
VolumeN/A
Net Assets1.36B
American Funds Growth Fund of Amer R3
Price$70.16
Change+$0.52 (+0.75%)
VolumeN/A
Net Assets283.8B
GLCGX vs RGACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GLCGX vs. RGACX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLCGX is a StrongBuy and RGACX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 284B vs. GLCGX (1.36B). RGACX pays higher dividends than GLCGX: RGACX (0.08) vs GLCGX (0.00). GLCGX was incepted earlier than RGACX: GLCGX (28 years) vs RGACX (23 years). GLCGX (0.95) and RGACX (0.94) have similar cost to investors . GLCGX is a more actively managed with annual turnover of: 215.00 vs. RGACX (25.00). RGACX has a lower initial minimum investment than GLCGX: RGACX (250) vs GLCGX (1000). RGACX annual gain was more profitable for investors over the last year : 3.09 vs. GLCGX (-2.71). RGACX return over 5 years is better than : 42.06 vs. GLCGX (-12.47).
GLCGXRGACXGLCGX / RGACX
Total Expense Ratio0.920.9498%
Annual Report Gross Expense Ratio0.950.94101%
Fund Existence28 years23 years-
Gain YTD-9.459-2.542372%
Front Load6%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.36B284B0%
Annual Yield % from dividends0.000.08-
Returns for 1 year-2.713.09-88%
Returns for 3 years4.0432.7912%
Returns for 5 years-12.4742.06-30%
Returns for 10 years23.0458.2840%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FLEX37.951.18
+3.21%
Flex Ltd
LYRA0.10N/A
+2.94%
Lyra Therapeutics
SUPV14.60N/A
N/A
Grupo Supervielle SA
DXC15.46-0.05
-0.32%
DXC Technology Company
BDSX0.42-0.02
-5.45%
Biodesix